ACON Investments Signs Definitive Agreement to Sell Vitalis to Laboratorios Sanfer

ACON Investments (“ACON”), a private equity investment firm based in Washington, D.C., announces a definitive agreement to sell Vitalis to Mexican multinational Laboratorios Sanfer. Vitalis is a Colombia-based manufacturer and wholesaler of injectable products used in hospitals, medical institutions and pharmacies across Latin America. The company has over 700 individual product registrations in more than 20 therapeutical areas, and a 45-year track record. “The team at Vitalis is enthusiastic to begin this new era of growth, consolidating its position as a key player in the Latin American pharmaceutical market. We are confident that Sanfer’s experience, know-how and leadership will exponentially boost the company’s growth and expansion plans,” commented Alberto Hernandez, Partner at ACON.

Read the full article: ACON Investments Signs Definitive Agreement to Sell Vitalis to Laboratorios Sanfer //

Source: https://www.prnewswire.com/news-releases/acon-investments-signs-definitive-agreement-to-sell-vitalis-to-laboratorios-sanfer-302038332.html

Leave a Comment

Your email address will not be published.

Scroll to Top